Dr. Ulrich Storz
Sr. Partner
Michalski Hüttermann & Partner
Personal Profile
Dr. Ulrich Storz obtained his PhD in Neurobiology from the University of M ü nster in 2002.
Subsequently, he received training as a German patent lawyer. In 2006, he became the agent of the European Patent Office.
Dr. Storz's main areas of expertise are patent application and patent execution and implementation, as well as free implementation search (FTO) analysis and preparation of expert opinions. He also provides consultation on patent strategy issues, particularly in the fields of life sciences (biotechnology, biophysics, biochemistry, and microbiology), especially in the area of therapeutic antibodies.
Dr. Ulrich Storz frequently participates in major antibody opposition proceedings at the European Patent Office. He also has extensive experience in gene editing technologies (including CRISPR, TALEN, and ZFN), as well as working in the fields of CAR-T cells, stem cell technology, plant biotechnology, and enzymes.
In addition, in recent years he has provided professional support for a large number of due diligence projects in the pharmaceutical/life sciences field, involving amounts ranging from 500000 euros to 100 million euros.
Dr. Storz organizes the "Rhein Biopharmaceutical Forum" annually and regularly publishes articles on therapeutic antibody patent issues in the mAbs journal. And he was named one of the most famous biotechnology patent lawyers in Germany by Juve Law magazine, and his name often appears in cases related to therapeutic antibodies at the European Patent Office“
Subsequently, he received training as a German patent lawyer. In 2006, he became the agent of the European Patent Office.
Dr. Storz's main areas of expertise are patent application and patent execution and implementation, as well as free implementation search (FTO) analysis and preparation of expert opinions. He also provides consultation on patent strategy issues, particularly in the fields of life sciences (biotechnology, biophysics, biochemistry, and microbiology), especially in the area of therapeutic antibodies.
Dr. Ulrich Storz frequently participates in major antibody opposition proceedings at the European Patent Office. He also has extensive experience in gene editing technologies (including CRISPR, TALEN, and ZFN), as well as working in the fields of CAR-T cells, stem cell technology, plant biotechnology, and enzymes.
In addition, in recent years he has provided professional support for a large number of due diligence projects in the pharmaceutical/life sciences field, involving amounts ranging from 500000 euros to 100 million euros.
Dr. Storz organizes the "Rhein Biopharmaceutical Forum" annually and regularly publishes articles on therapeutic antibody patent issues in the mAbs journal. And he was named one of the most famous biotechnology patent lawyers in Germany by Juve Law magazine, and his name often appears in cases related to therapeutic antibodies at the European Patent Office“
